ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $20,249,000 | -0.5% | 1,011,431 | +28.4% | 2.52% | +10.5% |
Q2 2018 | $20,347,000 | -10.1% | 787,723 | -16.8% | 2.28% | -26.3% |
Q1 2018 | $22,633,000 | -47.4% | 947,006 | -25.4% | 3.09% | -45.1% |
Q4 2017 | $43,044,000 | +19.5% | 1,270,123 | -25.4% | 5.64% | +31.0% |
Q3 2017 | $36,020,000 | +45.0% | 1,701,477 | +19.8% | 4.30% | +48.9% |
Q2 2017 | $24,839,000 | +19.1% | 1,420,156 | +19.2% | 2.89% | +37.4% |
Q1 2017 | $20,847,000 | +1.0% | 1,191,282 | -2.5% | 2.10% | -7.7% |
Q4 2016 | $20,643,000 | +7.6% | 1,221,463 | +4.5% | 2.28% | +32.9% |
Q3 2016 | $19,188,000 | +24.6% | 1,169,275 | +15.0% | 1.72% | +28.0% |
Q2 2016 | $15,397,000 | +96.0% | 1,017,000 | +87.2% | 1.34% | +116.8% |
Q1 2016 | $7,855,000 | – | 543,238 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |